Milestones :: Perspectives :: Research
Immunization Agenda 2030
Terms of Reference for Consultant – IA2030 Project Management
Universal Health Coverage and the Life Course (UHC-LC)
Department of Immunization, Vaccines and Biologicals (IVB)
Expanded Programme on Immunization (EPI)
Deadline for application: 1 January 2020
Purpose of the Consultancy
The purpose of this consultancy is to support the project management work of the “Immunization Agenda 2030: A Global Strategy to Leave No One Behind” (IA2030). The consultancy is proposed for a duration of six months (from early January 2020 through 30 June 2020), with the option to be renewed for an additional semester.
1. RFP Background
Immunization Agenda 2030
With the Global Vaccine Action Plan (GVAP) soon coming to an end, a new vision and strategy for vaccines and immunization for the coming decade has been in development over the past year. With this objective in mind, and at the request of the Regional Offices and partner organizations, WHO convened a technical consultation process over the course of 2019, to generate the post-2020 vaccines and immunization vision and strategy, which resulted in the development of “Immunization Agenda 2030: A Global Strategy to Leave No One Behind” (IA2030).
The IA2030 vision and strategy has been “co-created” through an iterative process, with extensive engagement of global, regional and country stakeholders. It builds on the lessons-learned from GVAP, but also responds to the new global context and addresses emerging challenges. IA2030 was endorsed by SAGE on 9 October 2019. The aim is to present the new vision and strategy for endorsement to the 73rd World Health Assembly, in May 2020.
The IA2030 core document is the first step. It will be complemented by a set of technical documents (technical “annexes”), fleshing out each strategic priority and guiding implementation of the IA2030 Strategic Framework. These will co-exist with other technical documents on an online resource repository. More importantly, the vision and strategy will need to be turned into practice through operational plans at the regional and country level, a governance mechanism and a Monitoring and Evaluation (M&E) Framework. Communications and advocacy will be a critical enabling component to ensure continued visibility and momentum throughout the decade.
Please refer to the Annex for more information on the workstreams.
Project Management Background
The project is overseen by a small core project team, made up WHO headquarters as the Secretariat, and partner agencies (WHO, UNICEF, The Bill and Melinda Gates Foundation (BMGF), Wellcome Trust and Gavi, The Vaccine Alliance, CSO constituency). At the WHO Secretariat, the Director of the Department of Immunization, Vaccines and Biologicals (IVB) provides overall supervision and strategic direction to the project, supported by one full time and three part time (10-50%) technical staff…more at title link above